Winter Promotion Save $120 + Free Shipping

GLP-1 Off-Ramp Planner: Free Cost Calculator

The GLP-1 Off-Ramp Planner calculates your personal path from full semaglutide treatment to micro-maintenance — showing exactly what happens to your yearly cost and hunger control at every step. Enter your current dose and months at goal weight. The calculator handles the rest.

MedVi Exclusive Tool

The Off-Ramp Planner

Worried about being on medication forever? See your personal path to micro-maintenance — and exactly what it does to your yearly cost.

Current Dose
Months at Goal Weight
6 months
1 mo24 mo
Your Current Yearly Cost
$2,988
$249/mo × 12

Your Timeline

NOW · 6 mo
TAPER
MICRO-MAINTENANCE
Month 1 Month 6 Month 8 Ongoing
Phase 1 · Month 6

Frequency Taper

Inject every 10 days instead of 7. Same 1.0mg dose — gives your body time to regulate hunger signals naturally.


Yearly Cost
$2,098 −30%
Phase 2 · Month 8

Micro-Maintenance

Low-dose 0.25mg every 10 days. The minimum signal needed to protect against rebound — at a fraction of the cost.


Yearly Cost
$1,254 −58%

By switching to the MedVi Maintenance Protocol, you could lower your yearly cost by 58% — from $2,988 down to $1,254/year — while protecting against rebound weight gain.

The MedVi Difference

We're the only clinic that plans your exit on Day 1.

Take the Assessment →

For illustrative purposes only. Individual results vary. Consult your MedVi provider before adjusting your protocol.

Methodology

How This Calculator Works

Every number comes from a real source — not an assumption. Here is the science and math behind each output.

1

The Pharmacokinetics Behind the Taper

The 10-day injection frequency is not arbitrary — it is grounded in semaglutide's 7-day elimination half-life. When you inject every 10 days instead of every 7, plasma drug concentrations at trough drop to approximately 65–70% of what they would be on a weekly schedule. That range sits above the threshold required for clinically meaningful GLP-1 receptor occupancy and appetite modulation, which is why the every-10-day taper is the protocol MedVi uses rather than a more aggressive reduction. Stretching beyond 14 days begins to push trough levels below the range that reliably prevents hunger hormone rebound. Read: Semaglutide Every 10 Days — Does It Still Work? →

2

How the Cost Math Is Calculated

On a standard weekly protocol, a patient takes 52 injections per year. At every-10-days frequency, that drops to approximately 36.5 injections per year — a 29.8% reduction in annual medication usage, which the calculator rounds to 30% for Phase 1. Phase 2 applies both that frequency reduction and a switch to 0.25mg compounded semaglutide, the lowest-dose tier in MedVi's pricing. The result is the ~58% total cost reduction you see in the Phase 2 output. Both figures are calculated against your selected starting dose at MedVi's current 2025–2026 compounded pricing, before any promotions are applied.

3

What the Output Means

The results this calculator produces are illustrative models based on MedVi's published compounded semaglutide pricing tiers and standard protocol timelines. They are not a medical recommendation or a guaranteed cost projection. Your actual off-ramp plan — including the timing of your taper, the exact doses used, and the total duration — is personalized by a licensed MedVi provider based on your clinical history, weight stability data, and treatment response. Use this tool to understand the financial picture before starting that conversation.

Is This Tool For You?

Who Should Use This Calculator

Five situations where this tool gives you a number you couldn't otherwise get without a consultation.

💊

Patients currently on full-dose weekly semaglutide

If you are paying for a full weekly dose and wondering whether you could maintain your results for less, this calculator models your exact Phase 1 and Phase 2 cost at your current dose — before you need to ask your provider anything.

🎯

Anyone who has been at goal weight for 3+ months

Weight stability at goal is one of the key readiness signals for beginning a structured taper. If that describes you, this tool shows what the financial picture looks like when you start the conversation with your provider — so you're not going in blind on the cost side.

🔄

Patients who stopped cold turkey and are considering restarting

Abrupt discontinuation leads to significant weight regain for most patients — the STEP 1 extension data shows roughly 66% of lost weight returns within 12 months. If you stopped without a plan and experienced that rebound, restarting with an exit protocol built in from day one is a different treatment pathway. This calculator lets you model what that costs before committing.

Clinical Background

About the MedVi Micro-Maintenance Protocol

~700 words covering what it is, why it works, and why most clinics don't offer it.

What micro-maintenance is — and why the rebound data makes it necessary

GLP-1 micro-maintenance refers to sustaining a sub-therapeutic dose of semaglutide — typically 0.25mg every 10 days — after a patient has reached and stabilized at their goal weight. At this dose and frequency, the medication is not driving further weight loss. It is doing something more specific: maintaining the minimum GLP-1 receptor signal needed to prevent the acute hormonal rebound that occurs when semaglutide is removed abruptly.

That rebound is well-documented and significant. The STEP 1 trial extension study, the most rigorous long-term data available on semaglutide discontinuation, found that patients who stopped treatment regained approximately two-thirds of their lost weight within 12 months of stopping. The mechanism is not willpower. It is biology: ghrelin surges, leptin sensitivity drops, and the body's set-point defense system activates in full force once the GLP-1 suppression is removed. Micro-maintenance exists to dampen that response long enough for the body's weight-regulatory system to recalibrate at its new set point.

📖

Source: Wilding JPH et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension." Diabetes, Obesity and Metabolism, 2022. View on PubMed →

The two-phase structure: how the protocol works in practice

The MedVi Off-Ramp Protocol uses a structured two-phase approach rather than a single step-down, because the goal is to give your body time to adapt at each new drug level before moving to the next reduction. Phase 1 is a frequency taper: you continue at your current dose but inject every 10 days instead of 7, running for 8 to 12 weeks. This stretches your injection schedule to approximately 36 doses per year instead of 52, which reduces annual medication costs by roughly 30% while keeping plasma concentrations within the effective maintenance window. Your body experiences meaningfully lower peak exposure with each cycle, giving hunger-signaling pathways time to begin adjusting.

Phase 2 is the micro-maintenance phase: you switch to 0.25mg — the lowest available dose — still at the every-10-day frequency. This is the minimum effective signal. It is not designed to suppress appetite at therapeutic levels. It is designed to prevent the acute rebound by keeping GLP-1 receptor activity above baseline while the body works toward a new stable equilibrium. Most patients on Phase 2 report mild hunger differences on days 9 and 10, which is expected and manageable. Weight stability in this phase is the target outcome, not further loss. You can read more about what patients experience on this schedule in MedVi's guide to microdosing semaglutide.

Why most clinics don't offer this: GLP-1 telehealth is a subscription model. Recurring monthly prescriptions at full therapeutic doses generate predictable, high-margin revenue. An exit strategy that reduces your dose to 0.25mg every 10 days cuts that revenue by more than half. There is no financial incentive for a clinic to build an off-ramp — unless patient outcomes are the actual priority. That is the structural tension this protocol is designed to resolve.

What MedVi does differently

Every MedVi patient receives an off-ramp timeline from their first provider consultation. Not as an afterthought, not as an optional add-on, but as a built-in component of the initial treatment plan. The readiness criteria — weight stability for a minimum of 3 consecutive months, total treatment duration of at least 9 to 12 months, demonstrated behavioral sustainability, and provider sign-off — are reviewed at each check-in so that the transition to Phase 1 happens at the right moment clinically, not just financially. Patients who are not yet ready stay on full-dose treatment. Patients who meet criteria have a clear, costed path forward.

If you want to understand the full clinical framework behind the stopping decision — including the specific data on duration, timing, and what the readiness checklist looks like in practice — the most complete resource is MedVi's guide to stopping semaglutide safely.

The Two Phases at a Glance

Phase 1 · 8–12 Weeks
Frequency Taper

Same dose, every 10 days instead of 7. Plasma levels drop to ~70% of trough, preserving appetite modulation while beginning hormonal adaptation.

~30% cost reduction
Phase 2 · Ongoing
Micro-Maintenance

0.25mg every 10 days. Minimum effective GLP-1 signal to prevent hormonal rebound — not for weight loss, for weight protection.

~58% total cost reduction
6-Month Mark
Provider Review

Weight stability check. Continue micro-maintenance, adjust frequency, or discuss full discontinuation — based on your clinical data, not a fixed timeline.

Read the Complete Stopping Guide →
Patient Voices

What It Feels Like to Have an Exit Plan

The fear of lifetime dependency is the most common reason people delay starting treatment. Here is what changed for patients who found the off-ramp.

I almost didn't start because I was terrified of being on injections forever. My last provider never mentioned stopping — it just wasn't part of the conversation. Knowing MedVi had a real exit plan built into my treatment from month one made the whole thing feel different. I've been on micro-maintenance for four months now and my weight hasn't moved more than two pounds.

— Sarah M., lost 38 lbs
Now paying $108/mo vs $249

I stopped cold turkey at another clinic when I hit my goal and gained back 22 pounds in three months. When I came to MedVi to restart, they showed me this calculator before I even filled out my intake form. The fact that there was a specific plan — not just "we'll figure it out" — is what made me sign up. I've been on the off-ramp protocol for six months. The weight has stayed off.

— David K., restarted with structured off-ramp
Avoided the $3,000/yr full-dose trap

The every-10-days schedule is honestly barely noticeable most of the time. Days 8 and 9 I feel slightly hungrier than usual, but I know it's coming now and I plan around it. For $1,254 a year instead of $2,988, I will absolutely take it. My MedVi provider says my weight data is as stable as it was on full weekly dosing. That was the thing I needed to hear.

— Renee T., 14 months on micro-maintenance
Saving $1,734 per year
FAQ

Frequently Asked Questions

Six questions from the People Also Ask box for GLP-1 maintenance cost and tapering queries — with detailed answers and links to deeper resources.

At 0.25mg every 10 days — the MedVi micro-maintenance dose — most patients pay approximately $100 to $125 per month through MedVi's compounded semaglutide program. That is roughly 58% less than standard weekly dosing at a therapeutic maintenance dose. Your exact cost depends on your starting dose and the length of your taper; use the Off-Ramp Planner above to model your specific scenario.
Yes, for most patients. Semaglutide has a 7-day half-life, which means roughly 65–70% of the drug's trough blood concentration is preserved on a 10-day injection schedule compared to weekly dosing. That level of GLP-1 receptor occupancy is sufficient to maintain meaningful appetite modulation and protect against the acute hunger hormone rebound that drives weight regain after stopping. Clinical pharmacokinetic data published in Clinical Pharmacokinetics (2021) supports the viability of extended-interval dosing for maintenance purposes. Read the full pharmacokinetics breakdown →
Yes, under provider supervision. The MedVi Off-Ramp Protocol transitions patients from their current maintenance dose to a frequency taper (same dose, every 10 days instead of 7) and then to a low-dose micro-maintenance phase (0.25mg every 10 days) once they have been stable at goal weight for at least 3 consecutive months and meet the other clinical readiness criteria. Dose reduction without a structured taper plan significantly increases the risk of rebound weight gain — the STEP 1 trial extension data shows two-thirds of lost weight returns within 12 months after abrupt discontinuation. Read the complete guide to stopping semaglutide →
GLP-1 micro-maintenance is the practice of sustaining a sub-therapeutic dose of semaglutide — typically 0.25mg every 10 days — after reaching and stabilizing at goal weight. At this dose and frequency, the medication is not designed to drive further weight loss. Instead, it preserves the minimum GLP-1 receptor signal needed to prevent the acute rebound of appetite-stimulating hormones (particularly ghrelin) that surges when semaglutide is stopped abruptly. MedVi's protocol combines a frequency taper in Phase 1 with a dose reduction in Phase 2 to give the body time to adapt at each step. Learn more about semaglutide microdosing →
The four key readiness signals MedVi providers look for are: (1) stable at goal weight for at least 3 consecutive months with no meaningful fluctuation, (2) at least 9–12 months of total semaglutide treatment to allow adequate metabolic recalibration, (3) demonstrated sustainable eating behaviors that do not rely entirely on appetite suppression, and (4) provider review and agreement on a personalized taper schedule. Stopping at goal weight rather than after a period of weight stability — a very common mistake — substantially increases regain risk. Read the full readiness guide →
Yes. MedVi offers compounded semaglutide at all maintenance and micro-maintenance doses, including the 0.25mg dose used in Phase 2 of the Off-Ramp Protocol. Compounded semaglutide through MedVi is significantly more affordable than branded Ozempic or Wegovy, is prescribed through a licensed provider network with ongoing check-ins, and ships free directly to patients. HSA and FSA payments are accepted. Compare compounded GLP-1 costs →

Why are over 20 million patients taking GLP-1 medicine? It works.

On average, patients taking GLP-1 medication lose an astounding 15-20% of their body weight.

Average weight loss
0 %
Patients call it the most effective treatment to date.
0 /10
Average waist reduction
0 "
Kept the weight off
0 %

Begin your weight loss journey with MEDVi.

Start your transformation today with MEDVi’s easy, personalized process for accessing GLP-1 medications. Designed with your convenience in mind, their streamlined approach ensures you’re supported every step of the way, from approval to receiving your prescription.

Get Approved

Complete a quick online evaluation to determine if GLP-1 medication is right for you. Their team of licensed professionals will review your information and provide approval in no time.

Get Prescribed

Once approved, you’ll receive a personalized prescription tailored to your weight loss and health goals. Your care plan is designed to help you achieve lasting results safely and effectively.

Receive your Rx

Your medication will be shipped directly to your door for maximum convenience. With MEDVi, starting your treatment is as simple as opening your package and following their easy-to-use instructions.

Unlimited 24/7 support included.

MEDVi provides 24/7 access to a dedicated team of specialists, ensuring you have the support you need around the clock. With unlimited appointments, messaging and support, you can confidently reach out for guidance, ask questions, or address concerns at any time.

Why Choose MedVi Wellness?

Personalized Care

At MedVi Wellness, they focus on delivering personalized care tailored to your specific health and weight loss goals. Their expert team takes the time to understand your needs and provides customized GLP-1 medication plans to ensure the best possible results.

Experienced Professionals

Team at MedVi Wellness is made up of highly experienced healthcare professionals who specialize in metabolic health and weight management. With extensive knowledge of GLP-1 medications, they guide you through every step of your journey to achieve sustainable health improvements.

Advanced Treatments

MedVi Wellness offers the latest in GLP-1 medication treatments, including semaglutide and tirzepatide injections and oral tablets. These advanced medications help regulate appetite, promote weight loss, and improve metabolic health, providing you with the most effective tools for lasting wellness.

Ongoing Support

They believe in offering continuous support throughout your health journey. At MedVi Wellness, you’ll have access to regular check-ins and personalized adjustments to ensure your GLP-1 medication treatment is working effectively. Their team is always available to address any concerns.

Proven Results

MedVi Wellness has a track record of helping clients achieve real, lasting results with GLP-1 medications. Their treatments have successfully supported clients in reaching their weight loss and metabolic health goals, offering a proven path to improved wellbeing and a healthier lifestyle.

Convenient Locations

With convenient locations across the United States, MedVi Wellness makes it easy for you to access high-quality GLP-1 medication treatments. Their clinics are designed to offer a comfortable, welcoming environment, making your health journey as smooth and convenient as possible.

Over 5,200+ Trusted Reviews

“When nothing else worked… MEDVi did.

Want to drop 23% of
your body weight?

It’s not magic—it’s metabolic science . GLP-1 medications work by mimicking natural hormones that regulate appetite and blood sugar, improving your metabolism and knocking out cravings.

Select your current weight:
200
lbs
Weight loss:
46
lbs

Unlimited 24/7 support included.

MEDVi provides 24/7 access to a dedicated team of specialists, ensuring you have the support you need around the clock. With unlimited appointments, messaging and support, you can confidently reach out for guidance, ask questions, or address concerns at any time.

MEDVi Guarantee

The only thing you'll lose is extra weight.

They're so confident in their program, they guarantee you'll lose the weight or your money back. It's that simple.